Plume Stars Overview

  • Founded
  • 2013
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $55.3K
Latest Deal Amount
  • Investors
  • 2

Plume Stars General Information


Developer of antibiotics intended to treat lung infections in patients affected by Cystic Fibrosis. The company discovers novel orphan medicines with the help of technologies applied to different APIs for innovative medicines with a primary interest in inhalation, enabling patients to get antibiotics that can easily treat them.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Strada Inzani, 1
  • 43125 Parma
  • Italy
+39 320 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Plume Stars Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 31-Oct-2019 $55.3K Completed Startup
1. Accelerator/Incubator 02-Sep-2013 Completed Startup
To view Plume Stars’s complete valuation and funding history, request access »

Plume Stars Executive Team (4)

Name Title Board Seat Contact Info
Paolo Colombo Co-Founder & Chief Executive Officer
Anna Balducci Co-Founder
Francesca Buttini Co-Founder
Ruggero Bettini Co-Founder
To view Plume Stars’s complete executive team members history, request access »

Plume Stars Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
European Union Government 000 0000 000000 0
Seedlab Accelerator/Incubator 000 0000 000000 0
To view Plume Stars’s complete investors history, request access »